Adverse effects of prolactin in rodents and humans: breast and prostate cancer (Q37246047)

19 August 2017

1 reference

title

Adverse effects of prolactin in rodents and humans: breast and prostate cancer (English)

1 reference

19 August 2017

1 reference

Philip W Harvey

1

1 reference

19 August 2017

David J Everett

series ordinal

2

1 reference

19 August 2017

Christopher J Springall

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Journal of Psychopharmacology

19 August 2017

1 reference

19 August 2017

22

1 reference

19 August 2017

2 Suppl

1 reference

19 August 2017

20-27

1 reference

Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin as an autocrine/paracrine growth factor in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

The role of prolactin in mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Evaluating the human relevance of chemically induced animal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Cancer risk among users of neuroleptic medication: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin as a mitogen in mammary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Rauwolfia and breast cancer: no relation found in long term users age fifty and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Development and potential clinical uses of human prolactin receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin: the new biology of an old hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Should prolactin be reconsidered as a therapeutic target in human breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Target organs in chronic bioassays of 533 chemical carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Carcinogenicity of antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Hyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin is a local growth factor in rat mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Early indicators for carcinogenesis in sex-hormone-sensitive organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Role of prolactin in chloro-S-triazine rat mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin acts as a potent survival factor for human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Lysyl oxidase interacts with hormone placental lactogen and synergistically promotes breast epithelial cell proliferation and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prostate development and carcinogenesis in prolactin receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

The survival effect of prolactin on PC3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Plasma prolactin and prostate cancer risk: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

A risk characterization for atrazine: oncogenicity profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Facilitation of dimethylbenz[a]anthracene-induced rat mammary tumorigenesis by restraint stress: role of beta-endorphin, prolactin and naltrexone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Plasma prolactin concentrations and risk of postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Prolactin involvement in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Dopamine antagonists and the development of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Role of Prolactin in Rat Mammary Carcinogenesis: Detection of Carcinogenicity of Low-Dose Carcinogens and of Persisting Dormant Cancer Cells 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Relationship of Blood Prolactin Levels and the Risk of Subsequent Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

Exercise-induced stress enhances mammary tumor growth in rats: Beneficial effect of the hormone melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881107082624

21 January 2018

Identifiers

DOI

10.1177/0269881107082624

1 reference

19 August 2017

1 reference